Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124917) titled 'A single-arm phase II clinical trial to explore the efficacy and safety of neoadjuvant intermediate fractionated radiotherapy combined with chemotherapy in patients with stage II-III soft tissue sarcoma' on May 19.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Peking University Cancer Hospital

Condition: Soft tissue sarcoma

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2025-09-10

Target Sample Size: treatment group:89;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=274780

Disclaimer: Curated by HT...